The Development of Quantitative Ultrasound Imaging Software Platform

Sponsor
Seoul National University Bundang Hospital (Other)
Overall Status
Enrolling by invitation
CT.gov ID
NCT05836246
Collaborator
(none)
196
1
66.9
2.9

Study Details

Study Description

Brief Summary

The goal of this observational study is to compare the image differences between conventional ultrasound and artificial intelligence-based ultrasound software in conscious adults.

The main question it aims to answer is to evaluate the effectiveness by determining that the new image analysis method is considered valid if it helps to identify more than 30% of histological characteristics.

Participants will undergo the examination using the two methods mentioned earlier after signing the consent form.

Study Design

Study Type:
Observational [Patient Registry]
Anticipated Enrollment :
196 participants
Observational Model:
Other
Time Perspective:
Prospective
Official Title:
The Development of Artificial Intelligence (AI) Based High Performance Structural-functional and Quantitative Ultrasound Imaging Software Platform
Actual Study Start Date :
Sep 1, 2020
Anticipated Primary Completion Date :
Mar 31, 2026
Anticipated Study Completion Date :
Mar 31, 2026

Outcome Measures

Primary Outcome Measures

  1. Quantitative ultrasound information [5 years]

    Quantitative ultrasound images of heart, thyroid, and breast disease

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • People with heart disease, thyroid disease, breast disease, and liver disease.
Exclusion Criteria:
  • Someone who has received surgery on the target organ in question.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Seoul National University Bundang Hospital Seongnam Gyeonggi-do Korea, Republic of 13620

Sponsors and Collaborators

  • Seoul National University Bundang Hospital

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Seoul National University Bundang Hospital
ClinicalTrials.gov Identifier:
NCT05836246
Other Study ID Numbers:
  • B-1910-570-301
First Posted:
May 1, 2023
Last Update Posted:
May 1, 2023
Last Verified:
Apr 1, 2023
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of May 1, 2023